BASIS OF PRESENTATION, MEASUREMENT AND CONSOLIDATION (Details Narrative) - USD ($)			9 Months Ended		12 Months Ended
	Oct. 25, 2023	Jun. 29, 2023	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021	Jun. 19, 2023
Reverse stock, shares split		1-for-6
Accumulated deficit			$ 123,099,681		$ 112,570,825
Working capital deficiency			14,690,000
Proceeds from issuance of debt							$ 11,756,563
Proceeds from issuance initial public offering						$ 14,545,805
Proceeds from short term debt			744,333	$ 1,889,144	1,476,121
Debt conversion converted instrument amount	$ 250,000				$ 2,355,318
Net proceeds from additional convertible notes			36,460
Series B Preferred Stock [Member]
Debt conversion converted instrument amount			2,200,000
Net proceeds from additional convertible notes			1,900,000
Repayment of short term loans and promissory notes, net			$ 700,000
Economic Injury Disaster Loan [Member]
Proceeds from issuance of debt						$ 499,900
Common Stock [Member]
Issuance of common stock			20,846					20,846